Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Subklewe

Showing results (41-50 of 244) with videos related to

Pageof 25
Sort By:
The Lancet. Haematology|May 11, 2024
Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to managementKai Rejeski, Michael D Jain, Nirali N Shah, et al.
American Journal of Clinical Oncology|July 18, 2022
Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in OncologyJames H Lewis, Sophia K Khaldoyanidi, Carolyn D Britten, et al.
Med (New York, N.Y.)|February 28, 2026
T cell exhaustion in bi- and trispecific T cell engager therapy in hematologic malignancies: Mechanisms and implicationsAmelie Muth, Alessandra Holzem, Anne-Sophie Neumann, et al.
JMIR Public Health and Surveillance|May 15, 2020
A Web- and App-Based Connected Care Solution for COVID-19 In- and Outpatient Care: Qualitative Study and Application DevelopmentTimo Schinköthe, Mariano Rolando Gabri, Manfred Mitterer, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Sarcoid-Like Reaction in Non-Hodgkin's Lymphoma-A Diagnostic Challenge for Deauville Scoring on <sup>18</sup>F-FDG PET/CT ImagingMichael Winkelmann, Kai Rejeski, Marion Subklewe, et al.
Human Immunology|March 14, 2007
Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomibMarion Subklewe, Kathrin Sebelin-Wulf, Carola Beier, et al.
Leukemia Research|March 31, 2012
Advanced systemic mastocytosis as a mimicker of metastatic clear cell renal cell carcinomaChristoph Walz, Marion Subklewe, Hans-Peter Horny, et al.
Seminars in Cancer Biology|November 10, 2019
Determinants of response and resistance to CAR T cell therapyStefanie Lesch, Mohamed-Reda Benmebarek, Bruno L Cadilha, et al.
Oncoimmunology|September 14, 2016
Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patientsVeit Bücklein, Tina Adunka, Anna N Mendler, et al.
Nature Reviews. Gastroenterology & Hepatology|July 4, 2009
Hepatosplenic T-cell lymphoma in a patient with Crohn's diseaseFlorian Beigel, Matthias Jürgens, Cornelia Tillack, et al.
Pageof 25

Showing results (41-50 of 244) with videos related to

Sort By:
Pageof 25
The Lancet. Haematology|May 11, 2024
Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to managementKai Rejeski, Michael D Jain, Nirali N Shah, et al.
American Journal of Clinical Oncology|July 18, 2022
Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in OncologyJames H Lewis, Sophia K Khaldoyanidi, Carolyn D Britten, et al.
Med (New York, N.Y.)|February 28, 2026
T cell exhaustion in bi- and trispecific T cell engager therapy in hematologic malignancies: Mechanisms and implicationsAmelie Muth, Alessandra Holzem, Anne-Sophie Neumann, et al.
JMIR Public Health and Surveillance|May 15, 2020
A Web- and App-Based Connected Care Solution for COVID-19 In- and Outpatient Care: Qualitative Study and Application DevelopmentTimo Schinköthe, Mariano Rolando Gabri, Manfred Mitterer, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Sarcoid-Like Reaction in Non-Hodgkin's Lymphoma-A Diagnostic Challenge for Deauville Scoring on <sup>18</sup>F-FDG PET/CT ImagingMichael Winkelmann, Kai Rejeski, Marion Subklewe, et al.
Human Immunology|March 14, 2007
Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomibMarion Subklewe, Kathrin Sebelin-Wulf, Carola Beier, et al.
Leukemia Research|March 31, 2012
Advanced systemic mastocytosis as a mimicker of metastatic clear cell renal cell carcinomaChristoph Walz, Marion Subklewe, Hans-Peter Horny, et al.
Seminars in Cancer Biology|November 10, 2019
Determinants of response and resistance to CAR T cell therapyStefanie Lesch, Mohamed-Reda Benmebarek, Bruno L Cadilha, et al.
Oncoimmunology|September 14, 2016
Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patientsVeit Bücklein, Tina Adunka, Anna N Mendler, et al.
Nature Reviews. Gastroenterology & Hepatology|July 4, 2009
Hepatosplenic T-cell lymphoma in a patient with Crohn's diseaseFlorian Beigel, Matthias Jürgens, Cornelia Tillack, et al.
Pageof 25